Maypharm Launches Multi-Active Skin Solution HYALMASS AQUATOX
Aesthetic company Maypharm is set to launch HYALMASS AQUATOX, a new formulation combining five active ingredients for skin rejuvenation. The product targets the global aesthetic market.
SEOUL, South Korea – MAYPHARM, an international company specializing in aesthetics and cosmeceuticals, has announced the upcoming launch of HYALMASS AQUATOX. This new multi-active formulation is designed to meet the evolving demands of the global aesthetic market.
Rather than relying on a single trendy ingredient, HYALMASS AQUATOX combines five sought-after active components: PDRN, exosomes, botulinum peptide, GHK-Cu, and succinic acid. The company aims to address the growing global demand for multifunctional aesthetic solutions with this formulation.
The launch expands MAYPHARM's HYALMASS product line, following the interest generated by HYALMASS AQUA EXOSOME. As the market for advanced skin rejuvenation products grows, Maypharm emphasizes the importance of product authenticity and authorized distribution channels for HYALMASS products.
Through HYALMASS AQUATOX, MAYPHARM continues to broaden its portfolio by aligning with new aesthetic trends and consolidating multiple popular active ingredients into a single product concept. The company stated the product will be available soon.